Business Information
The group's principal activity is to develop medical imaging devices. These medical devices include the computed tomography laser mammography (ctlm(r)) that utilizes a proprietary laser and proprietary scanning geometry and reconstruction algorithms for the detection and analysis of tissue in the breast to indicate malignancy or benignancy. The group is in development stage and is currently conducting clinical trials for ctlm(r). In connection with the clinical trials, it is also developing a clinical atlas of the optical properties of benign and malignant tissues with respect to absorption and scattering parameters as laser light passes through the tissue. The ctlm(R) is designed to provide the physician with objective data for interpretation and further clinical work-up. The group has entered into distribution agreements with distributors in North America, the United Kingdom, bosnia, Brazil, Ecuador, egypt, Israel, jordan, Middle East, slovenia, syria and turkey.
|
|
Name |
Title
|
Email
|
| Jay Bendis | Co - Chmn. | Available | | Patrick Gorman | Co - Chmn., Certified Public Accountant | Available | | Sherman Lazrus | Co - Chmn. | Available | | Allan Schwartz | Co - Founder, Dir., CFO, Exec. VP | N/A | | Deborah O’brien | Sr. VP | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 676 | (7,163) | | 2005 | 375 | (7,313) | | 2004 | 733 | (8,403)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
